Launch of the European Research Project CARS Explorer

The CARS Explorer project, coordinated by Didier Marguet from the French National Institute for Health and Medical Research (Inserm Unit 631, CIML, Marseille), was officially launched in April in Marseille, France. CARS Explorer is a collaborative research project funded by the European Commission under the Health priority of the 7th Framework Programme. This highly interdisciplinary consortium brings together internationally renowned physicists, biologists and clinicians of six institutional bodies from four European countries and a French SME.

Financed for three years, CARS Explorer seeks to demonstrate the concept of innovative light-based contrasting technologies for functional in situ imaging in life science and biomedical research. The ultimate goal of the consortium is to develop an endoscope based on non-linear optics (NLO) and laser pulse phase shaping.

Today, NLO technologies allow primarily low-depth exploration. However, they present major opportunities at the morphological and molecular level which makes it an original tool for biomedical analysis without requiring preliminary sample preparation, thus providing real time information to the patients.

To bring the concept to the diagnostic level, Cars Explorer partners will explore the molecular and morphological NLO signatures associated with tumour development in skin cancer, one of the fastest growing cancers in Europe with an incidence increase of 5 to 7 % a year. (Source: Ligue contre le Cancer). The consortium will concentrate its efforts on the so designated Coherent Anti-Stokes Raman Scattering (CARS) microscopy technique which permits to produce real time 3D images of cells and tissues at a molecular level, without any labelling or staining.

The development of this novel imaging technology will allow an efficient use of our knowledge of cancer molecular modifications. Indeed, this project will have a major strategic and economic impact by providing a non-invasive functional exploration method for clinical research and treatment, in particular for the prevention, diagnosis and monitoring of cancer. In the end, "an imaging technology capable of providing in vivo information both at the cellular and molecular level would be an outstanding and decisive breakthrough. It is certain that such approaches will play an increasingly central part in oncology and clinical research as well in the treatment of patients affected by cancer" says Didier Marguet.

The CARS Explorer consortium is coordinated by the French National Institute for the Health and Medical research (Inserm) and includes the French National Centre for Scientific Research (CNRS), the de Duve Institute (Belgium), the University of Stuttgart (Germany), the University of Bath (UK), Mauna Kea Technologies SAS (a French SME specialised in minimally-invasive biomedical imaging) and Inserm Transfert SA (France).

For further information, please visit:
http://www.carsexplorer.eu

Most Popular Now

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

AI Body Composition Measurements can Pre…

Adiposity - or the accumulation of excess fat in the body - is a known driver of cardiometabolic diseases such as heart disease, stroke, type 2 diabetes, and kidney disease...

AI can Strengthen Pandemic Preparedness

How to identify the next dangerous virus before it spreads among people is the central question in a new Comment in The Lancet Infectious Diseases. In it, researchers discuss how...

'Future-Guided' AI Improves Se…

In the world around us, many things exist in the context of time: a bird’s path through the sky is understood as different positions over a period of time, and...

New AI Tool Scans Social Media for Hidde…

A new artificial intelligence tool can scan social media data to discover adverse events associated with consumer health products, according to a study published September 30th in the open-access journal...

Study Finds One-Year Change on CT Scans …

Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease...

New AI Tools Help Scientists Track How D…

Artificial intelligence (AI) can solve problems at remarkable speed, but it’s the people developing the algorithms who are truly driving discovery. At The University of Texas at Arlington, data scientists...

Yousif's Story with Sectra and The …

Embarking on healthcare technology career after leaving his home as a refugee during his teenage years, Yousif is passionate about making a difference. He reflects on an apprenticeship in which...

AI Tool Offers Deep Insight into the Imm…

Researchers explore the human immune system by looking at the active components, namely the various genes and cells involved. But there is a broad range of these, and observations necessarily...

New Antibiotic Targets IBD - and AI Pred…

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases...

Highland to Help Companies Seize 'N…

Health tech growth partner Highland has today revealed its new identity - reflecting a sharper focus as it helps health tech companies to find market opportunities, convince target audiences, and...